Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The meta-analysis included 11 trials with 82,140 participants, providing robust evidence of the efficacy of GLP-1 RAs in reducing stroke risk
VinuNavarroJHerrero-CerveraAGarca-CubasMAndrs-BlascoIMartnez-HervsSet alThe GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant mice by modulating macrophage phenotype
Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial
Casewell, N
No difference in stroke volume was observed between the experimental groups
Optimizing nutrition, diet, and lifestyle communication in GLP-1 medication therapy for weight management: A qualitative research study with registered dietitians
US$ 21.95
US$ 26.28
US$ 27.29
US$ 29.11
US$ 24.29
US$ 22.23
